EXOSOME ATLAS / 01
From cellular messages to skin rejuvenation, tissue repair and targeted delivery. Explore the opportunities in exosome science and where human research stands today.
Turkish and English · A guide to selected research
A shared name covers different preparations, purposes and levels of evidence. Choose an area to explore in depth.
Investigate additional benefit alongside existing procedures for skin texture, hydration and recovery.
The next milestone
Longer follow-up, blinded assessment and replication using the same preparation.
Develop new approaches targeting signals around the hair follicle.
The next milestone
Comparison with established treatments for the same diagnosis and independent replication.
Turn signals involved in tissue repair into measurable therapeutic tools.
The next milestone
Progress from early safety observations to adequately sized trials against standard care.
Read disease-related information less invasively and deliver cargo to selected molecular targets.
The next milestone
Tests that improve clinical decisions and delivery platforms validated in controlled efficacy studies.
Exosomes, extracellular vesicles and the secretome: the distinctions that make research easier to understand.
Make sense of research news through study phase, controls, sample size and follow-up.
Practical questions about product identity, route, regulatory status and cost.
PUBMED · 2016–2026
Positive signals and open questions, together. Every card links to the original publication.
2026 · 60 adults · randomized, unblinded · 12 weeks
Short-term incremental benefit signal; durability remains uncertain.
Original publication2026 · 7 participants · paired donor sites
No treatment-related adverse events reported; no significant healing-time difference.
Original publication2025 · phase I · single-arm pancreatic cancer study
Early safety and target engagement; comparative clinical benefit not yet established.
Original publication2025 · 16 men · uncontrolled · 12 months
Positive signal; EV and microneedling contributions cannot be separated.
Original publication2023 · 28 participants · randomized split-face · 12 weeks
Additional improvement in several skin measures; early evidence for one topical preparation.
Original publication2016 · 519 men in independent validation
Support for prostate biopsy decisions; neither treatment nor a stand-alone diagnosis.
Original publicationNo. Research also covers tissue repair, hair, diagnostic tests and targeted molecular delivery. Each application is at a different stage; evidence in one does not establish another.
No. Exosomes are a subgroup of extracellular vesicles, not live cells. PRP is platelet-rich plasma prepared from a person’s blood. Their contents and evidence are not interchangeable.
There is no single validated protocol for all products and purposes. Small, short studies do not guarantee lasting results. A plan must reflect the diagnosis and evidence for the exact preparation.
No. This portal explains the research field; it is not a service menu. Cancer, diagnostic and wound studies are included to explain medical developments. Individual options require a consultation.
This selected-literature guide is neither a service menu nor a systematic review. It does not imply that every application discussed is offered at the clinic.
Publisher: Dr. Hamza Gemici clinic ·
Editorial policy